KYMFABI Trademark

Trademark Overview


On Friday, February 1, 2019, a trademark application was filed for KYMFABI with the United States Patent and Trademark Office. The USPTO has given the KYMFABI trademark a serial number of 79254291. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 27, 2026. This trademark is owned by Idorsia Pharmaceuticals Ltd. The KYMFABI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, excluding products used in cell therapy or gene therapy or for treatment of blood diseases
kymfabi

General Information


Serial Number79254291
Word MarkKYMFABI
Filing DateFriday, February 1, 2019
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 27, 2026
Registration Number5830778
Registration DateTuesday, August 13, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2019

Trademark Statements


Goods and ServicesPharmaceutical products for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, excluding products used in cell therapy or gene therapy or for treatment of blood diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 27, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIdorsia Pharmaceuticals Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameIdorsia Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameIdorsia Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Thursday, March 14, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 22, 2019APPLICATION FILING RECEIPT MAILED
Saturday, April 13, 2019ASSIGNED TO EXAMINER
Saturday, April 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2019NOTICE OF PUBLICATION
Tuesday, May 28, 2019PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, September 12, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Monday, September 23, 2019FINAL DISPOSITION PROCESSED
Monday, September 23, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 11, 2019NOTIFICATION PROCESSED BY IB
Friday, December 11, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 27, 2026CANCELLED SECTION 71